Trademark applications and grants for Boston Biomedical Inc. Boston Biomedical Inc has 9 trademark applications. The latest application filed is for "BB503"
Patent Application | Date |
---|---|
SUBSTITUTED NAPHTHO[2,3-b]FURANS AS WATER-SOLUBLE PRODRUGS FOR PREVENTING AND/OR TREATING CANCER 20200392098 - 17/005597 BAN; Hitoshi ;   et al. | 2020-12-17 |
Compositions for Treating and/or Preventing Cancer 20200237711 - Li; Chiang Jia ;   et al. | 2020-07-30 |
NOVEL GROUP OF STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL PATHWAY INHIBITORS 20200039948 - 16/236948 Li; Chiang Jia ;   et al. | 2020-02-06 |
2-ACETYLNAPHTHO[2,3-B]FURAN -4,9-DIONE FOR USE ON TREATING CANCER 20190388382 - 16/543089 Li; Chiang Jia ;   et al. | 2019-12-26 |
New Naphtho[2,3-B]Furan Derivatives 20190375723 - 16/463162 Ban; Hitoshi ;   et al. | 2019-12-12 |
NCAGE Code | 4RA48 | BOSTON BIOMEDICAL INC. |
CAGE Code | 4RA48 | BOSTON BIOMEDICAL INC. |
SEC | 0001451145 | BOSTON BIOMEDICAL INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.